Cholinergic Nicotinic Agonist [EPC]

61214 reported adverse events

Drugs of this class: NICOTINE POLACRILEX NICOTINE NICOTINE PATCHES NICOTINE TRANSDERMAL SYSTEM NICOTINE TRANSDERMAL PATCHES NICOTINE POLACRILEX MINI ARSENICUM ALB., BENZOICUM ACIDUM, BERBER. VULG., BRYONIA, CALADIUM SEGUINUM, CANTHARIS, CEANOTHUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CINCHONA, DAPHNE INDICA, IGNATIA, IRIS VERSICOLOR, LYCOPODIUM, NICOTINUM, NUX VOM., RHUS TOXICODENDRON, SCUTELLARIA LATERIFLORA, TABACUM, ECHINACEA, TARAXACUM, VALERIANA NICOTINE TRANSDERMAL SYSTEM PATCH NICOTINE18% MENTHOL 0.3% QUIT SMOKING NICOTINE QUIT SMOKING PATCHES 14MG NICOTINE PATCHES

These side effects are most commonly reported by patients taking drugs of the Cholinergic Nicotinic Agonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 7659
1 NICOTINE DEPENDENCE 6185
2 NAUSEA 4699
3 INTENTIONAL DRUG MISUSE 3782
4 APPLICATION SITE ERYTHEMA 3567
5 APPLICATION SITE PRURITUS 3517
6 DIZZINESS 2627
7 PRODUCT QUALITY ISSUE 2503
8 MALAISE 2409
9 PRODUCT ADHESION ISSUE 2362
See all common reactions for Cholinergic Nicotinic Agonist [EPC]

Drugs of the Cholinergic Nicotinic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NICOTINE DEPENDENCE 6185 0.7944
1 TOBACCO POISONING 70 0.6481
2 VAGINAL FLATULENCE 188 0.6205
3 APPLICATION SITE BRUISING 35 0.5738
4 RHESUS INCOMPATIBILITY 68 0.5620
5 TRUNCUS ARTERIOSUS PERSISTENT 77 0.3869
6 APPLICATION SITE HYPERAESTHESIA 28 0.2828
7 APPLICATION SITE DERMATITIS 251 0.2684
8 APPLICATION SITE URTICARIA 493 0.2194
9 APPLICATION SITE PERSPIRATION 33 0.1908
See all enriched reactions for Cholinergic Nicotinic Agonist [EPC]